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Carbohydrate restriction with postmeal walking effectively mitigates postprandial 
hyperglycemia and improves endothelial function in type 2 diabetes 
Abstract 
Postprandial hyperglycemia has deleterious effects on endothelial function. Restricting carbohydrate 
intake and postmeal walking have each been shown to reduce postprandial hyperglycemia, but their 
combination and subsequent effects on endothelial function have not been investigated. Here, we sought 
to examine the effect of blunting postprandial hyperglycemia by following a low-carbohydrate diet, with or 
without postmeal walking exercise, on markers of vascular health in type 2 diabetes (T2D). In a 
randomized crossover design, individuals with T2D (n < 11) completed three 4-day controlled diet 
interventions consisting of 1) low-carbohydrate diet alone (LC), 2) low-carbohydrate diet with 15-min 
postmeal walks (LC > Ex), and 3) low-fat control diet (CON). Fasting blood samples and brachial artery 
flow-mediated dilation (%FMD) were measured before and after each intervention. Total circulating 
microparticles (MPs), endothelial MPs, platelet MPs, monocyte-platelet aggregates, and adhesion 
molecules were assessed as biomarkers of vascular health. There was a significant condition = time 
interaction for %FMD (P < 0.01), with post hoc tests revealing improved %FMD after LC > Ex (>0.8 ± 1.0%, 
P < 0.02), with no change after LC or CON. Endothelial MPs were significantly reduced with the LC diet by 
~45% (from 99 ± 60 to 44 ± 31 MPs/μl, P < 0.02), with no change after LC > Ex or CON (interaction: P < 
0.04). Total MPs were lower (main effect time: P < 0.02), whereas monocyte-platelet aggregates were 
higher (main effect time: P = 0.01) after all interventions. Plasma adhesion molecules and C-reactive 
protein were unaltered. Attenuating postprandial hyperglycemic excursions using a low-carbohydrate diet 
combined with postmeal walking appears to be an effective strategy to improve endothelial function in 
individuals with T2D. NEW & NOTEWORTHY Carbohydrate restriction and postmeal walking lower 
postprandial hyperglycemia in individuals with type 2 diabetes. Here, we show that the combination 
significantly improved endothelial function and that carbohydrate restriction alone reduced circulating 
endothelial microparticles in individuals with type 2 diabetes. Listen to this article's corresponding 
podcast at http://ajpheart.pod-bean.com/e/low-carb-diet-and-exercise-improve-endothelial-health/. 
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Abstract 24 
 25 
Postprandial hyperglycemia has deleterious effects on endothelial 26 
function. Restricting carbohydrate intake and postmeal walking have each been 27 
shown to reduce postprandial hyperglycemia but their combination and 28 
subsequent effects on endothelial function have not been investigated. Here, we 29 
sought to examine the effect of blunting postprandial hyperglycemia by following 30 
a low-carbohydrate diet, with or without postmeal walking exercise, on markers of 31 
vascular health in type 2 diabetes (T2D). In a randomized crossover design, 32 
individuals with T2D (N=11) completed three four-day controlled diet 33 
interventions consisting of i) low-carbohydrate diet alone (LC), ii) low-34 
carbohydrate diet with 15-minute postmeal walks (LC+Ex), and iii) Low-fat control 35 
diet (CON). Fasting blood samples and brachial artery flow-mediated dilation 36 
(%FMD) were measured before and after each intervention. Total circulating 37 
microparticles (MPs), endothelial MPs (EMPs), platelet MPs (PMPs), monocyte-38 
platelet aggregates (MPAs), and adhesion molecules were assessed as 39 
biomarkers of vascular health. There was a significant conditionXtime interaction 40 
for %FMD (p=0.01), with post-hoc tests revealing improved %FMD after LC+Ex 41 
(+0.8±1.0%, p=0.02), with no change after LC or CON. EMPs were significantly 42 
reduced with the LC diet by ~45% (from 99±60 to 44±31 MP/μL, p=0.02), with no 43 
change after LC+Ex or CON (interaction: p=0.04). Total MPs were lower (main 44 
effect time: p=0.02), whereas, MPAs were higher (main effect time: p<0.01) after 45 
all interventions. Plasma adhesion molecules and c-reactive protein were 46 
unaltered. Attenuating postprandial hyperglycemic excursions using a low-47 
carbohydrate diet combined with postmeal walking appears to be an effective 48 
strategy to improve endothelial function in individuals with T2D.  49 
 50 
 51 
 52 
 53 
 54 
New and Noteworthy 55 
Carbohydrate-restriction and post-meal walking lowers postprandial 56 
hyperglycemia in individuals with type 2 diabetes. Here, we show that the 57 
combination significantly improves endothelial function, and carbohydrate 58 
restriction alone reduces circulating endothelial microparticles, in individuals with 59 
type 2 diabetes.  60 
 61 
Abbreviations 62 
AUC = Area Under the Curve 63 
CON = Control low-fat diet 64 
CGM = Continuous glucose monitoring 65 
EMPs = Endothelial Microparticles 66 
FMD = Flow-Mediated Dilation 67 
HbA1c = Glycated Hemoglobin  68 
ICAM-1 = Intracellular Adhesion Molecule 1 69 
LC = Low-carbohydrate 70 
LC+Ex = Low-carbohydrate plus exercise 71 
MPs = Microparticles 72 
MPAs = Monocyte-platelet aggregates 73 
PMPs = Platelet Microparticles 74 
T2D = Type 2 diabetes 75 
VCAM-1 = Vascular Cell Adhesion Molecule 1 76 
Introduction 77 
Prevention of cardiovascular disease in individuals with type 2 diabetes 78 
(T2D) is a major treatment goal (29, 42). Within this, diet and exercise remain the 79 
cornerstone lifestyle therapies (42). Separately, and in combination, diet and 80 
exercise interventions significantly improve cardiovascular risk factors (24, 54, 81 
71). Increased risk for cardiovascular disease (CVD) in individuals with T2D is 82 
attributed to a multitude of factors including hyperglycemia, inflammation, 83 
oxidative stress and dyslipidemia (59). In addition, impaired flow-mediated 84 
dilation (FMD), a measure of endothelial function, is an early manifestation of 85 
CVD that disproportionately affects individuals with T2D (36). Markers of 86 
endothelial activation are also elevated in individuals with T2D (45); for example 87 
endothelial and platelet derived microparticles (extracellular vesicles which are 88 
released from apoptotic or activated cells) and monocyte-platelet aggregates 89 
(which reflect platelet activation and inflammation) are markedly elevated under 90 
hyperglycemic conditions, and are important novel pathogenic markers of 91 
vascular disease (2, 7, 43).  92 
 93 
Postprandial hyperglycemia has emerged as an independent risk factor for 94 
the development of diabetes complications, including vascular disease (8, 10). 95 
Postprandial hyperglycemia is particularly detrimental to endothelial function, as 96 
various studies have shown that postprandial glucose excursions can directly 97 
promote oxidative stress, activate inflammatory pathways, reduce nitric oxide 98 
bioavailability, and impair FMD (11, 13, 50). Combined epidemiological and 99 
experimental studies suggest that hyperglycemia-induced endothelial dysfunction 100 
could be a mechanistic link between postprandial glucose spikes and CVD risk 101 
(10).  102 
Dietary carbohydrate restriction is reemerging as an effective approach for 103 
glycemic control (1, 26). Given that the rise in blood glucose concentration 104 
following a meal is largely dependent on the carbohydrate composition (57), 105 
reducing exogenous carbohydrate intake at each meal is a logical strategy to 106 
lower postprandial glucose and insulin responses (31, 35, 53). However, despite 107 
the immediate improvements in hyperglycemia observed with carbohydrate 108 
restriction (52, 61, 65), there is strong apprehension surrounding the adoption of 109 
a low-carbohydrate diet because it is typically high in fat (i.e., a low-carbohydrate 110 
high-fat, LCHF diet) (46, 68). Following a high-fat meal, several studies have 111 
observed a transient impairment in endothelial function and increase in 112 
endothelial microparticles, which is typically attributed to postprandial 113 
hypertriglyceridemia (25, 64, 66, 70). Thus, by targeting one risk factor for 114 
endothelial dysfunction and CVD risk (i.e., postprandial hyperglycemia) a LCHF 115 
diet may introduce another (postprandial hypertriglyceridemia). However, studies 116 
showing detrimental effects of dietary fat on the endothelium have been acute 117 
single meal studies, often involving combined high-fat and high-carbohydrate 118 
loads using shakes and/or fast food meals (25, 64, 66, 70). The response to 119 
several days of meals reflecting contemporary LCHF meals in T2D patients is 120 
unknown.  121 
Exercise has well-established benefits for vascular and overall health (34), 122 
and thus may be an attractive addition to a LCHF diet to maximize glucose 123 
lowering effects while mitigating any potential impairments caused by increasing 124 
dietary fat. Specifically, postmeal walking has been shown to markedly reduce 125 
postprandial hyperglycemia (22, 54) and lipemia (38, 56) in individuals with, and 126 
at risk for, T2D. However, to the best of our knowledge, no study has combined 127 
these two lifestyle approaches in an effort to optimize a lifestyle strategy for T2D.  128 
The aim of the present study was to examine the effects of four days of a 129 
low-carbohydrate diet, with or without daily postmeal walking, on endothelial 130 
function and biomarkers of vascular health, in individuals with T2D. Given that 131 
carbohydrate restriction leads to significant weight loss and metabolic 132 
adaptations in the first few weeks to months, we chose a short-term (four days) 133 
intervention in this initial study in order to reduce the confounding effect of these 134 
factors on endothelial function outcomes (6, 16).  135 
 136 
Methods 137 
Overview 138 
Individuals with physician-diagnosed T2D (HbA1c >6.5%, FPG >7.0 139 
mmol/L, or 2-h glucose OGTT >11.1 mmol/L; CDA (32)) were recruited to 140 
complete three, short-term controlled intervention periods in a randomized 141 
crossover design. Interventions for this proof-of-concept study were conducted 142 
across four days, to reduce the confounding influence of body composition 143 
changes, and to improve compliance and standardization. All food was provided 144 
to participants and diets were matched for energy and protein content. 145 
Accelerometers (Actigraph wGTX3+) were worn to monitor activity for all 146 
conditions and confirm the completion of post-meal walks. This trial was 147 
registered with clinicaltrials.gov (#NCT02683135) and approved by the UBC 148 
Clinical Research Ethics Board. Prior to study commencement participants 149 
provided written informed consent.  150 
 151 
Participants 152 
Sixteen (n=8 males/females) aged between 48-72 y, not on exogenous 153 
insulin and without diagnosed cardiovascular, kidney or any other diabetes 154 
complications were recruited from the local community. Individuals currently 155 
involved in a regular exercise routine (>3 days of structured exercise per week 156 
for last three months), following a low-carbohydrate diet or unwilling to consume 157 
the provided meat-containing diets were excluded. Five of the sixteen 158 
participants did not complete all three conditions, due to family reasons (n=1), 159 
inability or unwilling to follow study diets (n=3) and change of medications (n=1, 160 
addition of SGLT2 inhibitor after completing one condition). Therefore, eleven 161 
participants (7 females, who were all postmenopausal) were included in analyses 162 
and their baseline characteristics are shown in Table 1.  163 
 164 
Experimental Protocol 165 
Each participant attended a baseline screening session, which included 166 
the measurement of anthropometrics, a physical activity readiness questionnaire 167 
(PARQ+) and a Godin leisure time exercise questionnaire, followed by the three 168 
four-day interventions in a random order. The day before each intervention diet 169 
and activity were standardized, and a washout of 9-14 days occurred between 170 
each intervention where participants were asked to return to their normal diet and 171 
physical activity habits. Fasting blood for biomarkers of vascular health and 172 
brachial artery flow-mediated dilation (FMD) were measured before and after 173 
each four-day intervention at the same time of day following a consumption of a 174 
standardized mixed meal on the evening before the start of each intervention. 175 
During each intervention, a continuous glucose monitor (CGM) was worn to 176 
measure postprandial glucose responses. Incremental AUC was calculated using 177 
the trapezoid method (44). All intervention diets were isoenergetic, with calories 178 
estimated using the Harris benedict equation (39) and habitual intake (i.e., 179 
matched from first trial). An example meal plan for one-day of each diet is 180 
provided in Table 2. For the low-carbohydrate plus exercise condition (LC+Ex), 181 
the estimated individualized energy utilization for the postmeal walking (48) (~70 182 
kcal) was added to each meal to assure energy equilibrium between the three 183 
diets.  184 
 185 
Low-fat control diet (CON) 186 
Participants were provided a diet with meals based on the current dietary 187 
guidelines for adults with T2D comprising low-fat, low glycemic index, whole 188 
foods (23). Each meal comprised ~55% of total energy from carbohydrate 189 
(predominately from low glycemic index and high fibre carbohydrate sources), 190 
20% energy from fat (aiming for <7% saturated fatty acids); and 25% protein 191 
(primarily from lean meats).  192 
 193 
Low-carbohydrate high-fat diet (LC)  194 
Participants consumed a diet that provided the same energy content as 195 
the CON diet but with carbohydrates reduced to ~10% of total energy. The 196 
percent protein was matched at ~25%, with the remainder of the energy coming 197 
from fat (~65% of total kcal).  198 
 199 
Low-carbohydrate diet and exercise (LC+Ex) 200 
Participants performed 15 minutes of walking beginning ~30 minutes after 201 
breakfast, lunch and dinner. A similar strategy has been previously shown to 202 
reduce postprandial hyperglycemia in individuals with impaired glucose tolerance 203 
(22). The exercise intensity of the postmeal walking was light-to-moderate, which 204 
was confirmed on day-one of the intervention by having participants walk on a 205 
horizontal treadmill in the laboratory at a comfortable pace that elicited a rating of 206 
perceived exertion (RPE; CR-10 scale) of 3 ‘moderate’ (equating to ~60% of 207 
maximal heart rate). Participants were instructed to replicate this pace at home 208 
for each of the 15-minute postmeal walks for the remainder of the intervention. 209 
Accelerometers were worn to confirm compliance and intensity. Participants 210 
consumed the same diet as the LC intervention, but with the addition of ~70 kcal 211 
to each meal to account for the estimated energy expenditure of 15 minutes of 212 
walking.  213 
 214 
Physiological Measures 215 
 216 
Brachial artery flow-mediated dilation (FMD) 217 
Endothelial function was assessed with brachial artery FMD using high-218 
resolution ultrasound (Terason 3200) according to current guidelines (17, 62). 219 
First, a longitudinal section, 2-3 cm from the antecubital fossa of the brachial 220 
artery, was imaged for 1 minute using B mode ultrasound (insonation angle 221 
maintained at 60°). Then, a rapid inflation cuff positioned 1-2 cm distal from the 222 
olecranon process of the forearm was inflated to >60 mmHg above systolic blood 223 
pressure for 5 minutes. Simultaneous diameter and velocity measurements 224 
continued throughout and were recorded 30 seconds before and for 3 minutes 225 
after the cuff was rapidly deflated. Brachial blood pressure was measured using 226 
a manual sphygmomanometer and stethoscope. Mean arterial blood pressure 227 
(MAP) was calculated as 1/3*systolic blood pressure (SBP) + 2/3*diastolic blood 228 
pressure (DBP).  229 
Analyses for the synchronized diameter and velocity measures were performed 230 
using edge detection software (33, 72). FMD is expressed as the percent change 231 
in artery diameter from baseline (%FMD = 100*(Post – Preocclusionmean 232 
diameter/preocclusionmean diameter).   233 
 234 
Biomarkers of vascular health 235 
Collection of blood samples 236 
For adhesion molecules, venous blood was collected into EDTA 237 
containing tubes (BD Vacutainer) and the plasma obtained after centrifugation at 238 
1550Xg for 15 minutes at 4 C. For monocyte-platelet aggregate and 239 
microparticles analyses, venous blood was collected from the antecubital vein by 240 
venipuncture into sodium citrate tubes (BD Vacutainer). Monocyte-platelet 241 
aggregates were analyzed from whole blood 10 min after blood collection (details 242 
below). Plasma was generated by centrifugation for 15 min at 1550 g and stored 243 
at -80 °before batch analyses were performed (described below).  244 
 245 
Monocyte platelet aggregates (MPA) 246 
Exactly 10 minutes following blood collection, 90 μL of whole blood was 247 
transferred from the sodium citrate vacutainer into a TruCount tube (BD 248 
Biosciences, New Jersey, USA). 10 μL of FcR blocking reagent (Miltenyi Biotec, 249 
Germany) was added and the sample was then incubated in the dark at room 250 
temperature for 10 minutes. Following this, 2 μL of CD14-Vioblue (Miltenyi 251 
Biotec) and 10 μL of CD42b-APC (BD Biosciences) were added and gently 252 
mixed before incubation under the same conditions. Finally, 1 mL of red blood 253 
cell lysis buffer was added before incubation on a rocking platform for 15 254 
minutes. The sample was then analyzed on a flow-cytometer (Miltenyi Biotec 255 
MACSQuant Analyzer) with monocyte platelet aggregates defined as events 256 
positive for both CD14 and CD42b (51). Fluorescence-minus-one controls were 257 
used to determine positive staining for both CD14 and CD42b events.  258 
 259 
Circulating Microparticles  260 
Microparticles were characterized using flow cytometry, as previously 261 
described (4, 30). For the quantification of total microparticles (MPs), endothelial 262 
microparticles (EMP), and platelet microparticle (PMP) subspecies, plasma 263 
samples were centrifuged at 13,000g for 2 minutes and 200μL of platelet free 264 
plasma was then transferred to a TruCount tube (BD Biosciences, New Jersey, 265 
USA). MP size threshold was established using Megamix-Plus SSC calibrator 266 
beads (Megamix-Plus SSC beads, Biocytex, Marseille, France), and only events 267 
<1 μm in size were counted (Nielsen et al, 2014). Total MPs were defined as 268 
events falling within the Megamix-Plus SSC established size range (0.16, 0.20, 269 
0.24 and 0.5 μm). Cellular specific MP lineage was determined by flourochrome 270 
staining for endothelial (CD62e) and platelet (CD62p) specific antibodies and 271 
falling within the respective MP size range (BioLegend, San Diego, California). 272 
Samples were incubated with antibodies for 20 minutes in the dark at room 273 
temperature. Following incubation, samples were fixed with 2% 274 
paraformaldehyde (ChemCruz Biochemicals, Santa Cruz, California), diluted with 275 
PBS, and analyzed using BD Biosciences FACSAria I High Speed Cell sorter 276 
and flow cytometer (University of Colorado Anschutz Medical Campus Allergy 277 
and Clinical Immunology/Infectious Disease Flow Core). The concentration of 278 
total MPs, EMPs and PMPs were determined using the formula: ([number of 279 
events in region containing MPs /number of events in absolute count bead 280 
region] x [total number of beads per test / total volume of sample]).  281 
 282 
 283 
Adhesion molecules, c-reactive protein (CRP) and Serum amyloid A (SAA) 284 
Plasma was thawed, mixed and diluted 1000-fold before analyses of 285 
Intracellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 286 
(VCAM-1), CRP and SAA were made using the V-PLEX Vascular Injury Panel 2 287 
Human Kit (Meso Scale Discovery, Maryland, USA), according to the 288 
manufacturer’s instructions. Measures were made in duplicate and analyzed on a 289 
MESO QuickPlex SQ 120 (Meso Scale Discovery), with an intra-assay coefficient 290 
of variation 3.7%.  291 
 292 
Statistics 293 
All data were first tested for normality using Q-Q plots and are reported as 294 
mean and standard deviation (SD) or 95% confidence intervals. Data were 295 
analyzed using linear mixed model, with repeated measures of condition (CON, 296 
LC and LC+Ex) and time (pre, post) as fixed factors with SPSS 22.0 (SPSS, 297 
Chicago, Illinois). Post-hoc analyses using Tukey’s procedure were used to 298 
evaluate within condition changes (i.e., pre versus post) following significant 299 
interactions. Statistical significance was set at p < 0.05. Magnitude-based 300 
inference analyses were performed according to contemporary views on 301 
statistical reporting, allowing for clinically meaningful inference (5) using the 302 
spreadsheet available from http://www.sportsci.org. The smallest clinically 303 
beneficial threshold for %FMD was +1%, based on a recent meta-analyses which 304 
showed a 13% reduced risk of future cardiovascular events for every 1% 305 
improvement in %FMD (95% CI: 9% to 17%) (41). For measurements with an 306 
unknown smallest clinical change threshold, the default Cohen’s d of 0.2 was 307 
used.  308 
 309 
 310 
Results 311 
Figure 1A shows the 24 hour CGM curves for CON, LC, and LC+Ex 312 
conditions (n=11). LC and LC+Ex for four-days reduced the incremental blood 313 
glucose area under the curve (iAUC) by ~86  21% and ~94  22%, respectively 314 
compared to CON (p=0.01, Figure 1B). The change in body mass was not 315 
different between interventions (-1.9 ± 0.8 kg, main effect of time, p<0.01). 316 
However, the change in body mass was not different between conditions 317 
(Interaction: p=0.82) supporting successful matching of energy intake across 318 
diets.  319 
 320 
Flow-mediated dilation (%FMD) 321 
There was a significant condition X time interaction (p=0.01) for the 322 
change in %FMD. %FMD was significantly increased after LC+Ex (by +0.81 ± 323 
0.95%, p=0.02, Figure 2), with no change following CON and LC (both p>0.12, 324 
Figure 2). The probability that the change in %FMD with LC+Ex is 325 
beneficial/negligible/harmful based on the clinically meaningful change (+1%) 326 
was 25/75/0% (95% CI 1.6, 0.04%), respectively. For the CON and LC conditions 327 
the probability was 0/61/40% and 11/88/1%, beneficial/negligible/harmful, 328 
respectively. Baseline diameter and time to peak diameter did not change across 329 
time or between conditions (Table 3).  330 
 331 
Microparticles 332 
There was a significant condition X time interaction (p=0.04) for the 333 
change in EMPs. EMPs were significantly reduced after the LC condition (by 334 
65%, p=0.04, Figure 3), with no change following CON and LC+Ex (both p>0.12, 335 
Figure 3). The probability that the change in EMPs with LC is 336 
beneficial/negligible/harmful was 95/4/1%, respectively (Cohen’s d 0.81). For the 337 
CON and LC+Ex conditions the probability was 6/26/68% and 17/42/41%, 338 
beneficial/negligible/harmful, respectively. A significant main effect of time 339 
(p=0.02) revealed a collective 45% reduction in total microparticles (from 8790 ± 340 
6036 to 5865 ± 4327 MP/μL). The probability that the change in circulating 341 
microparticles is beneficial/negligible/harmful was 94/6/0%, respectively (Cohen’s 342 
d 0.52, Table 4). Platelet microparticles (PMPs) did not differ significantly 343 
between conditions (Interaction: p=0.07, Table 3).  344 
 345 
Monocyte platelet aggregates (MPA), c-reactive protein and adhesion molecules 346 
A significant main effect of time (p<0.01) revealed a collective 14% 347 
increase in total (count/mL) monocyte-platelet aggregates (interaction: p=0.15, 348 
Table 4). The probability that the change in monocyte-platelet aggregates is 349 
beneficial/negligible/harmful was 1/5/94%, respectively (Cohen’s d 0.71, Table 350 
4). %MPA (interaction: p=0.78, time: p=0.08, Table 3), plasma adhesion 351 
molecules (ICAM-1, VCAM-1), SAA and c-reactive protein (all p>0.12) were not 352 
significantly changed following all conditions (Table 3). Pairwise comparisons for 353 
the magnitude based inference for each condition is provided in Table 4.  354 
 355 
Discussion 356 
The present study examined the short-term effects of a low-carbohydrate 357 
diet, with and without postmeal walking exercise, on endothelial function and 358 
markers of vascular health in individuals with T2D. We tested whether the 359 
attenuation of postprandial hyperglycemia with a low-carbohydrate diet and 360 
postmeal walking (LC+Ex) might represent an optimal strategy for improving 361 
endothelial function and markers of vascular health. The main findings of the 362 
present study were that i) LC+Ex significantly improved endothelial function 363 
assessed by FMD, and ii) LC alone lowered circulating endothelial microparticles. 364 
No changes were observed in the selected measures of vascular health following 365 
a low-fat CON diet based on current diabetes guidelines (3, 14). Additionally, 366 
total circulating microparticles were reduced, however monocyte-platelet 367 
aggregates were slightly increased, following all short-term conditions. The 368 
present study shows that attenuating postprandial hyperglycemia by restricting 369 
carbohydrates and postmeal walking can improve vascular health in individuals 370 
with T2D. The addition of postmeal walking to a low-carbohydrate high-fat diet 371 
may mitigate the purported deleterious effects of high-fat meals on endothelial 372 
function seen in some (19, 25, 66, 70) but not all (67) investigations and further 373 
research is warranted to determine this in larger, longer interventions.    374 
 375 
Postprandial hyperglycemia, exacerbated by carbohydrate consumption at 376 
meals, contributes to the excess CVD risk in individuals with T2D (8, 11, 18). 377 
Elevated blood glucose levels following an oral glucose load (13) or oscillating 378 
glucose infusion (11) impairs endothelial function. However, antioxidant, statin 379 
and/or insulin therapies that reduce glycemia and oxidative stress, can restore 380 
endothelial function, at least in an acute setting (12). In the present study, the 381 
aim was to reduce postprandial hyperglycemic excursions with lifestyle 382 
interventions, namely carbohydrate-restriction and postmeal walking. Continuous 383 
glucose monitoring confirmed the reduction in postprandial hyperglycemia with 384 
LC alone and in combination with postmeal walking, compared to the currently 385 
recommended low-fat diet (CON). Indeed, postprandial hyperglycemia assessed 386 
by iAUC was reduced by 86% and 94%, respectively, with short-term LC and 387 
LC+Ex. Furthermore, endothelial function was increased after LC+Ex. The 388 
observed reduction in postprandial hyperglycemia with LC+Ex was larger than 389 
that typically seen with Acarbose treatment (a drug to delay carbohydrate 390 
digestion and thus postprandial hyperglycemia) (20). Acute Acarbose 391 
administration before a sucrose load has been shown to mitigate postprandial 392 
endothelial dysfunction (69). As well, long-term trials show that Acarbose 393 
treatment reduces the incidence of diabetes and prevents CVD (15, 37). 394 
However, there is a high prevalence of adverse gastrointestinal symptoms with 395 
Acarbose use (15, 37). Here, we show for the first time that lowering postprandial 396 
hyperglycemia with the non-pharmacological combination of a low-carbohydrate 397 
high-fat diet and postmeal walking improves endothelial function in individuals 398 
with T2D. Therefore, this lifestyle combination may be effective for reducing 399 
vascular dysfunction in T2D.  400 
 401 
The postprandial period is associated with a cascade of proatherogenic 402 
events, including endothelial and immune cell activation (9). Circulating 403 
microparticles are biologically active submicron particles that are shed from the 404 
membrane of cells under conditions of stress/injury (21). Studies have shown 405 
that circulating microparticles are indicative of endothelial dysfunction in 406 
individuals with T2D (27). Indeed, endothelial microparticles carry and express 407 
endothelial proteins such as adhesion molecules and integrins, and thus disturb 408 
vascular homeostasis (21). Acutely, previous studies have shown an increase in 409 
endothelial microparticles (EMPs) following a high-fat meal, indicating endothelial 410 
activation (28, 60). However, in the present study EMPs were reduced following 411 
four-days of a low-carbohydrate high-fat diet. This is likely attributed to the 412 
reduction in postprandial hyperglycemic excursions with carbohydrate-restriction 413 
compared to the low-fat diet in individuals with T2D. Indeed, oscillating blood 414 
glucose is more deleterious for oxidative stress than constant high glucose in 415 
those with T2D (11). However, it is unclear why the same decrease in EMPs was 416 
not seen following the LC+Ex condition. There is some evidence to suggest that 417 
this may be due to exercise induced shear-stress, which mediates microparticle 418 
shedding from the vascular wall (49). Following a single session of exercise, 419 
studies have reported a transient increase in microparticles, and have attributed 420 
this to increased shear stress and/or oxidative stress (47, 49, 58). In this regard, 421 
acute exercise prior to a high-fat meal may not acutely lower endothelial 422 
microparticles (40), however repetitive exposure to exercise over several weeks 423 
may improve defense systems. Indeed, regular exercise improves endothelial 424 
function and vascular health, which appears to be primarily mediated by shear 425 
stress and increased nitric oxide bioavailability (55, 63). Thus, it is possible that 426 
the addition of three postmeal walks in the LC+Ex condition was promoting 427 
vascular remodeling in the previously inactive T2D participants, which may have 428 
led to a different EMP response when compared to the LC diet alone.  429 
 430 
The present study did not include an exercise only, low-fat CON condition. 431 
Although it is hypothesized that the reduced postprandial hyperglycemia with the 432 
LC diet combined with exercise has additive and may have unique effects on the 433 
vasculature, further research is needed to compare exercise alone to low-434 
carbohydrate diet approaches. Previous research has shown that postmeal 435 
walking while following a low-fat diet reduces 24-h blood glucose (22) and 436 
postprandial iAUC (54) by ~11%. The present study shows that the combination 437 
of low-carbohydrate diet and postmeal exercise lowers four-day iAUC by 94%, 438 
compared to low-fat CON diet alone. A low-carbohydrate diet alone lowered the 439 
four-day iAUC by ~86%. Therefore it appears that a low-carbohydrate diet 440 
approach is much more potent than postmeal walking for lowering glucose levels 441 
but our study cannot ascertain the independent and combined effects of each 442 
approach.  443 
Interestingly, the total microparticle count was reduced after all conditions 444 
suggesting that all diets altered circulating microparticle concentration. This is 445 
most likely driven by the decrease in EMPs following the LC and PMPs following 446 
the LC+Ex conditions. However the CON diet, which comprised of low-fat, low 447 
glycemic index, whole foods (23), is likely a less processed and ‘healthier’ diet 448 
than typically consumed by participants. Thus, this improvement in overall food 449 
quality may underlie the resulting decrease in microparticles after all conditions 450 
(independent of changes in glycemic control). The reduction in body mass 451 
experienced after all three short-term diet conditions generally supports that the 452 
provided diets were healthier or lower in calories and this could have played a 453 
role. It is unknown whether the observed change in microparticle count might be 454 
the result of altered microparticle production and/or clearance, which are areas 455 
that require further research. Furthermore, the microparticle species, cargo and 456 
subsequent physiological signaling could be different regardless of total 457 
microparticle concentration (73).  458 
 459 
Conclusion 460 
 In individuals with T2D, postprandial hyperglycemia is particularly 461 
concerning as it contributes to CVD risk through impairing endothelial function, 462 
increasing oxidative stress, and promoting inflammation (11, 13, 50). The results 463 
of the present study show that controlling postprandial hyperglycemia with a low-464 
carbohydrate high-fat diet combined with postmeal walking exercise improves 465 
endothelial function in individuals with T2D. Microparticles, as markers of 466 
endothelial activation, were reduced with short-term carbohydrate restriction. 467 
Carbohydrate restriction and postmeal exercise may therefore represent an 468 
effective strategy to mitigate the negative effects of postprandial hyperglycemia 469 
and reduce CVD risk in individuals with T2D. Further research is needed to 470 
elucidate the long-term impact of carbohydrate restriction and postmeal exercise 471 
on CVD risk factors in individuals with, and at risk for, type 2 diabetes.  472 
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Tables and Figures 482 
 483 
 484 
Table 1. Baseline characteristics of participants (n=11).  485 
Age 
(y) 
Body 
mass 
(kg) 
BMI 
(kg/m2) 
Waist 
circumference 
(cm) 
HbA1c 
(%) 
Years of 
diagnosis 
Blood 
Pressure 
(mmHg) 
64 ± 
8 
91 ± 
18 
34 ± 8 105 ± 13 7 ± 1 6 ± 4 93 ± 4 
Medications: Metformin = 9, GLP-1 = 1, DPP4 = 1, Sulfonylurea = 1, 
Statin = 3 
HbA1c = glycated hemoglobin, BMI = Body mass index, Duration T2D = years 486 
diagnosed with T2D. 487 
 488 
 489 
Table 2. Example meal plan showing the three meals provided for one day of 490 
each intervention (500 kcal/meal version).  491 
Diet CON (low-fat) LC (low-carb) LC+Ex 
Goal 
macronutrient ratio 
(CHO:PRO:fat) 
55%:25%:20% 10%:25%:65% 10%:25%:65% 
Breakfast 95g-Oats 
25g-Whey 
30g-Blueberries 
30g-Raspberries 
150g-Whole Egg 
110g-Egg Whites 
55g-Avocado 
30g-Peppers 
40g-Onions 
40g-Carrots 
10g-Almonds 
150g-Whole Egg 
110g-Egg Whites 
55g-Avocado 
30g-Peppers 
40g-Onions 
40g-Carrots 
10g-Almonds 
Lunch 105g-Chicken 
Breast 
230g-Yams 
40g-Green Beans 
17g-Cashew 
 
105g-Ground 
Turkey 
38g-Cashew nuts 
15g-Olive oil 
35g-Spinach 
30g-Carrots 
30g-Cucumber 
105g-Ground 
Turkey 
38g-Cashew nuts 
15g-Olive oil 
35g-Spinach 
30g-Carrots 
30g-Cucumber 
Dinner 100g-Turkey 
85g-Brown Rice 
14g-Cashew 
40g-Brocolli  
100g-Steak (Rib 
eye)  
30g-Cahsew nuts 
13g-Olive Oil 
30g-Apple 
30g-Spinach 
50g-Cucumber 
100g-Steak (Rib 
eye)  
30g-Cahsew nuts 
13g-Olive Oil 
30g-Apple 
30g-Spinach 
50g-Cucumber 
CON = Control low-fat moderate-carbohydrate diet, LC = low-carbohydrate diet, 492 
LC+Ex = low-carbohydrate plus postmeal walking, CHO= carbohydrate, PRO = 493 
protein.  494 
Table 3. Flow-mediated dilation (n=11), microparticles (n=9), monocyte-platelet 495 
aggregates (n=11), adhesion molecules, serum amyloid and c-reactive protein 496 
(n=11) data before and after each four-day condition.  497 
 CON LC LC+Ex Interaction Main 
effect 
 Pre Post Pre Post Pre Post P value P value 
Baseline 
diameter 
(mm) 
0.39 
± 
0.07 
0.41 
± 
0.09 
0.39 
± 
0.06 
0.40 
± 
0.06 
0.40 
± 
0.06 
0.40 
± 
0.07 
0.15 0.11 
Peak 
diameter 
(mm) 
0.42 
± 
0.07 
0.44 
± 
0.08 
0.42 
± 
0.06 
0.44 
± 
0.07 
0.43 
± 
0.06 
0.44 
± 
0.06 
0.33 0.11 
Time to 
peak (s) 
51.3 
± 
35.3 
50.0 
± 
26.7 
51.1 
± 
27.1 
47.2 
± 
30.4 
44.6 
± 
36.9 
60.1 
± 
47.1 
0.48 0.67 
PMPs 
(MP/μL) 
42.1 
± 
26.5 
46.1 
± 
31.7 
33.2 
± 
30.8 
33.9 
± 
21.5 
50.8 
± 
20.0 
28.8 
± 
25.6 
0.07 0.34 
Total MPA 
(cells/μL) 
77.5 
± 
21.7 
95.5 
± 
22.7 
80.2 
± 
20.5 
92.7 
± 
27.9 
77.3 
± 
20.0 
87.1 
± 
19.0 
0.15 <0.01 
%MPA 29.8 
± 5.5  
31.3 
± 5.5 
31.0 
± 6.4 
32.7 
± 5.4 
31.0 
± 6.4 
31.3 
± 7.8 
0.78 0.08 
CRP 
(mg/L) 
8.0 ± 
8.3 
7.9 ± 
8.5 
5.3 ± 
4.9 
8.2 ± 
8.4 
7.3 ± 
7.2 
9.3 ± 
11.4 
0.12 0.29 
SAA (mg/L) 5.7 ± 
4.2 
6.4 ± 
4.3 
3.9 ± 
2.5 
5.3 ± 
5.6 
5.3 ± 
3.4 
5.1 ± 
4.2 
0.72 0.30 
ICAM-1 
(ng/mL) 
461 
± 89 
478 
± 83 
368 
± 
111 
402 
± 77 
389 
± 
102 
422 
± 89 
0.44 0.19 
VCAM-1 
(ng/mL) 
392 
± 
249 
441 
± 
255 
320 
± 
208 
395 
± 
217 
389 
± 
252 
400 
± 
248 
0.48 0.06 
Data are mean ± SD. PMP = Platelet microparticle, MPA = Monocyte-platelet 498 
aggregate, CRP = c-reactive protein, SAA = Serum amyloid A, ICAM-1 = 499 
Intracellular adhesion molecule, VCAM-1 = Vascular cell adhesion molecule. 500 
 501 
 502 
 503 
 504 
 505 
 506 
 507 
 508 
 509 
 510 
 511 
 512 
Table 4. Pairwise comparisons using magnitude based inferences for the change 513 
in selected markers of vascular health measured before and after each four-day 514 
condition 515 
 516 
  CON LC LC+Ex 
Total MP Cohens d 0.4 0.9 0.6 
Beneficial/trivial/harmful 65/22/13% 96/3/1% 88/10/2% 
Qualitative Inference Possibly 
beneficial 
Very likely 
beneficial 
Likely 
beneficial 
PMPs Cohens d 0.1 0.8 0.1 
Beneficial/trivial/harmful 23/40/37% 97/3/0% 23/37/40% 
 Qualitative Inference Unclear Very likely 
beneficial 
Unclear 
MPA count Cohens d 0.9 0.6 0.5 
Beneficial/trivial/harmful 0/3/97% 2/11/88% 2/15/83% 
 Qualitative Inference Very likely 
harmful 
Likely 
harmful 
Likely 
harmful 
MPA % Cohens d 0.6 0.3 0.2 
Beneficial/trivial/harmful 2/11/88% 8/33/59% 9/41/50% 
 Qualitative Inference Likely 
harmful 
Unclear Unclear 
CRP Cohens d 0.0 0.5 0.2 
Beneficial/trivial/harmful 31/46/23% 3/17/80% 10/35/55% 
 Qualitative Inference Unclear Likely 
harmful 
Unclear 
SAA Cohens d 0.3 0.3 0.1 
Beneficial/trivial/harmful 11/29/60% 8/31/61% 40/34/25% 
 Qualitative Inference Unclear Unclear Unclear 
ICAM Cohens d 0.3 0.3 0.3 
Beneficial/trivial/harmful 11/29/60% 6/29/65% 8/32/60 
 Qualitative Inference Unclear Unclear Unclear 
VCAM Cohens d 0.6 0.9 0.1 
Beneficial/trivial/harmful 2/10/88% 1/3/96% 21/41/39% 
 Qualitative Inference Likely 
harmful 
Very likely 
harmful 
Unclear 
MP = Microparticle, PMP = Platelet microparticle, MPA = Monocyte-platelet 517 
aggregate, CRP = c-reactive protein, SAA = Serum amyloid A, ICAM-1 = 518 
Intracellular adhesion molecule, VCAM-1 = Vascular cell adhesion molecule. 519 
 520 
 521 
 522 
 523 
Figure 1. Continuous blood glucose data (n=11) showing 1A) the blood glucose 524 
excursions across four-days of a control low-fat diet (CON), low-carbohydrate 525 
diet (LC) and low-carbohydrate plus exercise (LC+Ex), and 1B) the incremental 526 
AUC for each four-day condition. # = p < 0.05 interaction, * = p < 0.05 post-hoc. 527 
 528 
 529 
Figure 2. Changes in flow-mediated dilation (FMD) before and after short-term 530 
control low-fat diet (CON), low-carbohydrate diet (LC) and low-carbohydrate plus 531 
exercise (LC+Ex) conditions. Group mean (Bar: n=11) and individual data (lines). 532 
# = p < 0.05 interaction, * = p < 0.05 post-hoc. 533 
 534 
Figure 3. Changes in endothelial microparticles (EMP) before and after short-535 
term control low-fat diet (CON), low-carbohydrate diet (LC) and low-carbohydrate 536 
plus exercise (LC+Ex) conditions. Group mean (Bar: n=9) and individual data 537 
(lines). # = p < 0.05 interaction, * = p < 0.05 post-hoc. 538 
 539 
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